Changing the Cancer Treatment Paradigm During the PandemicChanging the Cancer Treatment Paradigm During the Pandemic

Varian’s Chief Medical Officer, Deepak Khuntia talks about the company’s recent initiatives and being acquired by Siemens Healthineers.

Omar Ford

February 3, 2022

1 Min Read
IMG_2022-2-3-185630.jpg
Image Courtesy of Varian Medical Systems

Varian Medical Systems has gone through some profound changes in the last few years. The cancer care specialist was acquired by Siemens Healthineers in one of the largest medtech deals of the pandemic era.

Varian’s Chief Medical Officer, Deepak Khuntia appears on this episode of Let’s Talk Medtech, to discuss the company’s growth under Siemens Healthineers.  He also discusses the progress the company is making on developing its Flash Therapy – which is not yet commercially available.

He also shares insight on how to deliver cancer care and management during a pandemic in this unforgettable episode of Let’s Talk Medtech.

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like